This opportunity is no longer accepting applications.
grant RFA-DA-25-063

Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)

This grant opportunity seeks to fund research that analyzes microglial protein profiles in specific brain regions and cell types in relation to HIV and substance use disorder (SUD). The aim is to use these profiles to understand how microglia carrying HIV might contribute to brain-related health issues when HIV and SUD occur together.

The goal of this funding opportunity announcement is to generate brain region and cell-type specific microglial protein profiles in the context of HIV and SUD, then use those molecular profiles and interaction networks to establish mechanisms of how HIV-harboring microglia may contribute specifi…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Drug Abuse

Dates

Opportunity Released: August 23, 2024
Open for Submission: August 23, 2024
Submission Deadline: August 14, 2025
Application Window Closes: August 14, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.